EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Nutrition Video Series
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Nutrition Video Series
Ways to Give
About Us

Day

December 21, 2020

Gastric Cancer Registry Prepares to Launch Innovative Data Portal

The Gastric Cancer Registry is the first comprehensive repository of clinical and genomic data pertaining to stomach cancer. Its chief aims are...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk RNA screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 338
Millbrae, CA 94030

Administrative Office:
14600 Weston Parkway,
Cary, NC 27513

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Nutrition Video Series
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

19 hours ago

The targeted drug Cyramza combined with chemotherapy produced a disease-control rate of 81% in a trial of previously treated gastric cancer patients. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 days ago

ENHERTU® (fam-trastuzumab deruxtecan-nxki) from Daiichi Sankyo Co., Ltd. and AstraZeneca US Community Connections approved by the FDA for patients with advanced HER2-positive gastric cancer. In a phase 2 trial, the response rate to Enhertu was 40%, versus 11% for chemotherapy. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 days ago

We collect and curate the latest news in gastric cancer research. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

3 days ago

Merck won priority review from the U.S. Food and Drug Administration for KEYTRUDA (pembrolizumab) Injection 100 mg in combination with chemotherapy for the treatment of some patients with esophageal cancer. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 days ago

The Gastric Cancer Foundation offers ways to support gastric cancer research at any level you are comfortable with. For example, simply shopping on Amazon Smile can make a difference when you select the Gastric Cancer Foundation as your charity! smile.amazon.com/ch/27-2978173 ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

6 days ago

Taiho Oncology is presenting three studies at American Society of Clinical Oncology GI on Lonsurf, including one that found that treating gastric cancer patients in the second or third-line settings with the drug was effective regardless of which prior treatments they received. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

In just a few minutes you can identify all clinical trials that match your profile and the closest trial sites - all from the comfort of your home. We can also update you when new studies open that match your profile. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Gastric cancer patients who are malnourished prior to treatment faced worse treatment outcomes compared to those who maintained proper nutrition, according to a new study. onlinelibrary.wiley.com/doi/full/10.1002/cam4.3604?af=R ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Chemotherapy after surgery for gastric cancer was superior to chemoradiation in a recent trial. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

"My husband and I are a team in a greater way than we have ever been in our lives. We both have cancer, albeit in different ways" - a Smart Patient. Smart Patients is a resource for patients and their caregivers, who navigate the journey together. Find support from others online at gastriccancer.org/patient-resources/community-resources/ ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2019 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X